Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Mapping the Influence of Drugs of Abuse on Risk and Reward Circuits


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03475277

Organisation Name: Stanford University

Overal Status: Recruiting

Start Date: July 30, 2019

Last Update: July 12, 2022

Lead Sponsor: Stanford University

Brief Summary: This study is a biomarker study designed to characterize how ketamine impacts the reward circuits of the human brain.

Conditions:
  • Healthy


Total execution time in seconds: 0.3080780506134